Cargando…

Association of biological antirheumatic therapy with risk for type 2 diabetes: a retrospective cohort study in incident rheumatoid arthritis

OBJECTIVE: To explore possible associations of treatment with biological disease-modifying antirheumatic drugs (bDMARDs), including T-cell-based and interleukin-6 inhibition (IL-6i)-based therapies, and the risk for type 2 diabetes mellitus (T2DM) in patients with rheumatoid arthritis (RA). STUDY DE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paul, Sanjoy K, Montvida, Olga, Best, Jennie H, Gale, Sara, Pethö-Schramm, Attila, Sarsour, Khaled
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Rheumatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211068/ https://www.ncbi.nlm.nih.gov/pubmed/34135030 http://dx.doi.org/10.1136/bmjopen-2020-042246

Ejemplares similares

A retrospective cohort study: 10-year trend of disease-modifying antirheumatic drugs and biological agents use in patients with rheumatoid arthritis at Veteran Affairs Medical Centers
por: Ng, Bernard, et al.
Publicado: (2013)

Interruptions of biological and targeted synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: a descriptive cohort study assessing trends in patient characteristics in Switzerland
por: Burkard, Theresa, et al.
Publicado: (2022)

Dosage reduction and discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: protocol for a pragmatic, randomised controlled trial (the BIOlogical Dose OPTimisation (BIODOPT) trial)
por: Uhrenholt, Line, et al.
Publicado: (2019)

Evaluation of Access Disparities to Biologic Disease-Modifying Antirheumatic Drugs in Rural and Urban Communities
por: Peterman, Nicholas J, et al.
Publicado: (2022)

Biological tapering and sonographic flare in rheumatoid arthritis
por: Ko, Chi-Hua, et al.
Publicado: (2018)

Trajectory of intensive treat-to-target disease modifying drug regimen in an observational study of an early rheumatoid arthritis cohort
por: White, Douglas, et al.
Publicado: (2013)

Do solar cycles influence giant cell arteritis and rheumatoid arthritis incidence?
por: Wing, Simon, et al.
Publicado: (2015)

Biomarkers in Rheumatoid Arthritis
por: Shapiro, Samantha C
Publicado: (2021)

Effect of a 12-week high-intensity exercise intervention: a comparison of cardiac exercise adaptations during biological disease-modifying antirheumatic drug treatment (TNF inhibitors vs IL-6 signalling inhibitors) in patients with rheumatoid arthritis – study protocol for a randomised controlled trial
por: Jønck, Simon, et al.
Publicado: (2023)

Do biological disease-modifying antirheumatic drugs reduce the spinal fracture risk related to ankylosing spondylitis? A longitudinal multiregistry matched cohort study
por: Robinson, Yohan, et al.
Publicado: (2017)

Retrospective cohort study on risk of hearing loss in patients with rheumatoid arthritis using claims data
por: Huang, Chung-Ming, et al.
Publicado: (2018)

Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databases
por: Silvagni, Ettore, et al.
Publicado: (2018)

Role of Diet in Influencing Rheumatoid Arthritis Disease Activity
por: Badsha, Humeira
Publicado: (2018)

Evaluating the Use of Hydroxychloroquine in Treating Patients With Rheumatoid Arthritis
por: Nazir, Armaan M, et al.
Publicado: (2021)

Prevalence and Severity of Temporomandibular Disorders in Rheumatoid Arthritis Patients
por: Mustafa, Mohammad A, et al.
Publicado: (2022)

Safety Profile of Methotrexate Therapy in Patients With Rheumatoid Arthritis
por: Mustafa, Syed Hassan, et al.
Publicado: (2022)

Sweet’s Syndrome in a Patient With Seropositive Rheumatoid Arthritis After Starting Adalimumab: Is Sweet’s Syndrome Related to Rheumatoid Arthritis or Is It the Paradoxical Effect of Adalimumab?
por: Paul, Prodip, et al.
Publicado: (2021)

Efficacy and Safety of Tofacitinib in Rheumatoid Arthritis (RA): A Retrospective Study From Two Centers in Jeddah, Saudi Arabia
por: Alzahrani, Zeyad, et al.
Publicado: (2022)

Higher incidence of rheumatoid arthritis in patients with symptomatic osteoarthritis or osteoarthritis-related surgery: a nationwide, population-based, case–control study in Taiwan
por: Lu, Ming-Chi, et al.
Publicado: (2015)

Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts
por: Kiely, Patrick, et al.
Publicado: (2019)

A Rare Case of Multicentric Reticulohistiocytosis with Concurrent Rheumatoid Arthritis
por: Behera, Anupama, et al.
Publicado: (2019)

Foot Involvement as the First Manifestation in Rheumatoid Arthritis Patients in Lahore
por: Ali Khan, Sajid, et al.
Publicado: (2021)

Vapour, gas, dust and fume occupational exposures in male patients with rheumatoid arthritis resident in Cornwall (UK) and their association with rheumatoid factor and anti-cyclic protein antibodies: a retrospective clinical study
por: Murphy, Dan, et al.
Publicado: (2018)

Soluble CD24 is an inflammatory biomarker in early and seronegative rheumatoid arthritis
por: Zheng, Xi, et al.
Publicado: (2023)

Network analysis of depression and anxiety symptoms in Chinese rheumatoid arthritis patients
por: Zhang, Lijuan, et al.
Publicado: (2023)

Timing matters: real-world effectiveness of early combination of biologic and conventional synthetic disease-modifying antirheumatic drugs for treating newly diagnosed polyarticular course juvenile idiopathic arthritis
por: Huang, Bin, et al.
Publicado: (2020)

Patterns of multimorbidity and their effects on adverse outcomes in rheumatoid arthritis: a study of 5658 UK Biobank participants
por: McQueenie, Ross, et al.
Publicado: (2020)

Total glucosides of paeony for rheumatoid arthritis: a protocol for a systematic review
por: Luo, Jing, et al.
Publicado: (2016)

Factors Leading to Diagnostic and Therapeutic Delay of Rheumatoid Arthritis and Their Impact on Disease Outcome
por: Javaid, Umair, et al.
Publicado: (2023)

Prevalence of Latent Tuberculosis Infection (LTBI) in Mexican Patients With Rheumatoid Arthritis (RA)
por: Zavala del Ángel, Abel Eduardo, et al.
Publicado: (2023)

Understanding Heterogeneity in Patients’ Conceptualisation of Treatment for Rheumatoid Arthritis: A Cluster Analysis
por: Hsiao, Betty, et al.
Publicado: (2023)

Temporal summation of pain and ultrasound Doppler activity as predictors of treatment response in patients with rheumatoid arthritis: protocol for the Frederiksberg hospitals Rheumatoid Arthritis, pain assessment and Medical Evaluation (FRAME-cohort) study
por: Christensen, Anton Wulf, et al.
Publicado: (2014)

Can the painDETECT Questionnaire score and MRI help predict treatment outcome in rheumatoid arthritis: protocol for the Frederiksberg hospital's Rheumatoid Arthritis, pain assessment and Medical Evaluation (FRAME-cohort) study
por: Rifbjerg-Madsen, Signe, et al.
Publicado: (2014)

Tuberculosis among patients treated with TNF inhibitors for rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis in Slovenia: a cohort study
por: Rotar, Ziga, et al.
Publicado: (2020)

Strategies for developing and implementing a rheumatoid arthritis healthcare quality framework: a thematic analysis of perspectives from arthritis stakeholders
por: Barber, Claire, et al.
Publicado: (2021)

Evaluating associations of joint swelling, joint stiffness and joint pain with physical activity in first-degree relatives of patients with rheumatoid arthritis: Studies of the Aetiology of Rheumatoid Arthritis (SERA), a prospective cohort study
por: Hughes-Austin, Jan M, et al.
Publicado: (2021)

Cumulative inflammatory burden and obesity as determinants of insulin resistance in patients with established rheumatoid arthritis: cross-sectional study
por: Manrique-Arija, Sara, et al.
Publicado: (2021)

Relapse in rheumatoid arthritis patients undergoing dose reduction and withdrawal of biologics: are predictable factors more relevant than predictive parameters? An observational prospective real-life study
por: Vittecoq, Olivier, et al.
Publicado: (2019)

Association Between STAT4 rs7574865 Polymorphism and Rheumatoid Arthritis: Debate Unresolved
por: Tarakji, Iman, et al.
Publicado: (2018)

Factors of importance for reducing fatigue in persons with rheumatoid arthritis: a qualitative interview study
por: Feldthusen, Caroline, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bd4aqa1omckmbu4brem26ofi85